Last reviewed · How we verify
Immediate-release reference drug — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Immediate-release reference drug (Immediate-release reference drug) — Pfizer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Immediate-release reference drug TARGET | Immediate-release reference drug | Pfizer | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Immediate-release reference drug CI watch — RSS
- Immediate-release reference drug CI watch — Atom
- Immediate-release reference drug CI watch — JSON
- Immediate-release reference drug alone — RSS
Cite this brief
Drug Landscape (2026). Immediate-release reference drug — Competitive Intelligence Brief. https://druglandscape.com/ci/immediate-release-reference-drug. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab